Prostate cancer - androgen deprivation therapy
Known prostate cancer on androgen deprivation therapy (ADT) for 9 weeks - radiation therapy planning. Prostate specific antigen (PSA) - 2 months ago: 37 ng/mL.
Loading Stack -
0 images remaining
Quality: no major artefacts
Prostate size: 41 x 35 x 35 mm (CC x AP x ML) ≈ 26 mL.
Peripheral zone (PZ): diffusely hypointense on T2 and ADC and hyperintense on b1400
Transition zone (TZ): diffusely hypointense, indistinct margins of the pseudocapsule, loss of zonal boundaries
Prostate margin: broad capsular contact
Neurovascular bundles: close proximity, probably involved
Seminal vesicles: diffuse hypointensity along the ejaculatory duct and inferior portions of both seminal vesicles
Lymph nodes: oval external iliac lymph nodes (up to 5 mm size, fatty hilum, smooth margins)
Pelvic bones: small lesion in the right femoral head very likely bone island, no definite signs of bony metastasis
Side note: bilateral ureteric stents with the tip in the bladder
Shrunken prostate in a histologically proven prostate cancer with infiltration of both lobes on androgen deprivation therapy.
Signs of seminal vesicle invasion.
MRI putative stage: cT3bNxMx
2 case question available
Loading Stack -
0 images remaining
A small, markedly hypointense prostate with loss of zonal boundaries can be seen on the T2w and ADC images. There is some signal intensity of the prostatic gland on the DWI (b1400), more pronounced than the background (red arrows) with corresponding signal loss in the ADC images (blue arrows). However, the differentiation of tumor margins is compromised.
Marked hypointensity within the inferior portions of the seminal vesicles on T2w and ADC images together with increased signal in the b1400 images are highly suggestive of seminal vesicle invasion.
Histology of the systematic biopsy performed about 2 months earlier showed an acinar adenocarcinoma (modified Gleason score 4+4=8, ISUP grade 4/5) within 12/12 cores. There was also perineural nerve sheath infiltration bilaterally. TNM: pT3a
1 case question available
Biparametric MRI was done for radiation therapy planning and staging purposes.
The diffuse low signal intensity of the whole prostate gland in T2w and ADC images with loss of zonal boundaries and gland shrinkage as a result of atrophy/fibrosis has been described as a finding following androgen deprivation. This compromises the distinction of actual tumor margins 1-4.
The patient is intended for intensity-modulated radiotherapy.
- 1. Andreas M. Hötker, Yousef Mazaheri, Junting Zheng, Chaya S. Moskowitz, Joshua Berkowitz, Joshua E. Lantos, Xin Pei, Michael J. Zelefsky, Hedvig Hricak, Oguz Akin. Prostate Cancer: assessing the effects of androgen-deprivation therapy using quantitative diffusion-weighted and dynamic contrast-enhanced MRI. (2015) European Radiology. 25 (9): 2665. doi:10.1007/s00330-015-3688-1 - Pubmed
- 2. T. Barrett, A. B. Gill, M. Y. Kataoka, A. N. Priest, I. Joubert, M. A. McLean, M. J. Graves, S. Stearn, D. J. Lomas, J. R. Griffiths, D. Neal, V. J. Gnanapragasam, E. Sala. DCE and DW MRI in monitoring response to androgen deprivation therapy in patients with prostate cancer: A feasibility study. (2012) Magnetic Resonance in Medicine. 67 (3): 778. doi:10.1002/mrm.23062 - Pubmed
- 3. Anwar R. Padhani, A. David MacVicar, Connie J. Gapinski, David P. Dearnaley, Geoffrey J. M. Parker, John Suckling, Martin O. Leach, Janet E. Husband. Effects of Androgen Deprivation on Prostatic Morphology and Vascular Permeability Evaluated with MR Imaging1. (2001) Radiology. 218 (2): 365-74. doi:10.1148/radiology.218.2.r01ja04365 - Pubmed
- 4. Pritesh Patel, Melvy S. Mathew, Igor Trilisky, Aytekin Oto. Multiparametric MR Imaging of the Prostate after Treatment of Prostate Cancer. (2018) RadioGraphics. 38 (2): 437-449. doi:10.1148/rg.2018170147 - Pubmed